Background: Contemporary guidelines for managing nonvalvular atrial fibrillation (NVAF)
include apixaban and rivaroxaban as first-line anticoagulation treatment options. Minimal …

Background/Aims: Early studies on direct oral anticoagulants (DOACs) reported a higher risk
of gastrointestinal bleeding (GIB) compared with warfarin; however, recent studies have …

Atrial fibrillation (AF) poses a substantial risk of stroke, necessitating effective
anticoagulation therapy. This systematic review and meta-analysis (SRMA) evaluates the …

5. Syversen SW, Jørgensen KK, Goll GL, et al. Effect of therapeutic drug monitoring vs
standard therapy during maintenance infliximab therapy on disease control in patients with …

To the Editor A recent study1 showed that rivaroxaban was associated with a significantly
increased risk of major ischemic or hemorrhagic events compared with apixaban among …

В статье применительно к инсульту рассмотрена концепция «чистой клинической
выгоды»(net clinical benefit-NCB), роль прямых оральных антикоагулянтов во вторичной …

Background: Alzheimer's disease (AD) is characterized by cognitive dysfunction and
memory loss that is accompanied by pathological changes to white matter. Some clinical …

Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia and significantly
increases the risk of ischemic stroke, one of its most serious complications. The intricate …

To the Editor A recent study1 showed that rivaroxaban was associated with a significantly
increased risk of major ischemic or hemorrhagic events compared with apixaban among …

Background The efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K
antagonists (VKAs) for the treatment of patients with left-sided bioprosthetic heart valves …